Page last updated: 2024-10-30

metformin and Amphetamine-Related Disorders

metformin has been researched along with Amphetamine-Related Disorders in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yang, J1
Zhang, Z1
Xie, Z1
Bai, L1
Xiong, P1
Chen, F1
Zhu, T1
Peng, Q1
Wu, H1
Zhou, Y1
Ma, Y1
Zhang, Y1
Chen, M1
Gao, J1
Tian, W1
Shi, K1
Du, Y1
Duan, Y1
Wang, H1
Xu, Y1
Kuang, YQ1
Zhu, M1
Yu, J1
Wang, K1

Other Studies

1 other study available for metformin and Amphetamine-Related Disorders

ArticleYear
Metformin modulates microbiota-derived inosine and ameliorates methamphetamine-induced anxiety and depression-like withdrawal symptoms in mice.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 149

    Topics: Amphetamine-Related Disorders; Animals; Anxiety; Depression; Inosine; Metformin; Methamphetamine; Mi

2022